1974
DOI: 10.1001/archderm.110.4.619
|View full text |Cite
|
Sign up to set email alerts
|

Steroid rosacea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

1976
1976
2017
2017

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(5 citation statements)
references
References 1 publication
(1 reference statement)
0
5
0
Order By: Relevance
“…The role of Demodex folliculorum in human dermatopathology and particularly in rosacea has remained controversial [5]. Bonnar et al reported significantly increased mite densities in many types of rosacea including steroid-induced rosacea [15].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The role of Demodex folliculorum in human dermatopathology and particularly in rosacea has remained controversial [5]. Bonnar et al reported significantly increased mite densities in many types of rosacea including steroid-induced rosacea [15].…”
Section: Discussionmentioning
confidence: 99%
“…Chronic misuse of TCS on the face produced a clinical condition which was described by various names, like light sensitive seborrheid [2], perioral dermatitis [3], rosacea-like dermatitis [4]. steroid rosacea [5], steroid dermatitis resembling rosacea [6], and steroid-induced rosacea-like dermatitis [7]. Since there is no agreement on nomenclature, we prefer to promote the term steroid dermatitis resembling rosacea (SDRR) where it describes the morphology of the disease due to TCS abuse on the face.…”
Section: Introductionmentioning
confidence: 99%
“…The appearance is of a flaming red, scaly, papule-covered face. [79] Multiple pathways including rebound vasodilatation and proinflammatory cytokine release by chronic intermittent steroid exposure induce rosacea-like eruption. [11] The average duration of treatment required to produce adverse effects in most cases is 6 months or more, but it varies and is also potency dependent.…”
Section: Discussionmentioning
confidence: 99%
“…On theoret ical grounds we prefer HC 17-B to TA. This preference did not ensue from our trial, probably because its duration was too short; it can, however, be gathered from the literature that fluorinated corticosteroids should not be used on the face [4,6,9,10,14], (2) New patients with untreated and stronger changes may apply a topical nonfluorinated corticosteroid in addition to taking tetracycline at the beginning of treatment. More rapid improvement can thus be ex pected [9,10].…”
Section: Discussionmentioning
confidence: 99%